Urgent Field Safety Notice For Atellica Ch Enzymatic Hemoglobin A1c (a1c_e) By Siemens Healthcare Diagnostics Inc. Tarrytown
Summary Siemens Healthcare Diagnostics is issuing an urgent safety notice for its Atellica CH Enzymatic Hemoglobin A1c test used to measure blood sugar control in diabetic patients. The notice affects medical facilities in Germany and the EU that use this diagnostic device. The company has classified this as a Class I safety issue, which is the most serious category.
- Recalling firm
- Siemens Healthcare Diagnostics Inc. Tarrytown
- Product
- Atellica CH Enzymatic Hemoglobin A1c (A1c_E)
- Reason
- Urgent Field Safety Notice for Atellica CH Enzymatic Hemoglobin A1c (A1c_E) by Siemens Healthcare Diagnostics Inc. Tarrytown
- Classification
- Class I
- Category
- medical device recall
- Country
- Germany
- Agency
- BFARM
- Recall date
- 2026-07-27
- Status
- Ongoing
- Distribution
- Germany / EU
Official recall notice from BFARM
Recall details on Nibble Recalls: https://trynibble.app/recalls/9bed2e1d-c1f0-410c-ab7c-0013f3b55ce7